Beta Bionics, Inc. (NASDAQ: BBNX) has priced a $150 million public offering this week just as its product story is acquiring more commercial torque: FDA clearance for the Mint™ patch pump, a planned U.S. launch in the first quarter of 2027, and a…
Doximity, Inc. (NYSE: DOCS) may be sitting at the intersection of two stubborn healthcare realities: physicians are exhausted by administrative overload, and the system cannot easily afford to lose more of them. Its emerging AI opportunity is compelling precisely because it is not…
Amwell, Inc. (NYSE: AMWL, $12.40, up +152.55% YTD) is building a more investable telehealth narrative: less pandemic-era novelty, more enterprise healthcare infrastructure. Its second-quarter results suggest the company is translating a broad digital-care footprint into a steadier mix of recurring subscription revenue,…